Orna Therapeutics, which engineers immune cells inside the body, will fold into one of the world’s largest drugmakers. The ...

Precigen (PGEN) surged dramatically since the FDA approval of PAPZIMEOS, its first-in-class therapy for Recurrent Respiratory Papillomatosis (RRP).

The latest firm to top up its venture capital coffers is Austin, Texas-based Santé Ventures, which on Monday announced its ...

Krystal Biotech (KRYS) stock gains as the company wins FDA RMAT designation for its lung cancer therapy KB707. Read more here ...

Immunology biotech Agomab Therapeutics is seeking to raise up to $212.5 million in its Nasdaq debut, joining a series of biotechs chipping away at 2025’s iced-over IPO market. | Immunology biotech ...

Eli Lilly will acquire Orna Therapeutics for up to $2.4 billion to gain access to the Watertown biotech's circular RNA ...

The companies Aktis Oncology, Alumis, and Parabilis Medicines bagged the biggest biotech funding rounds overall in January ...

Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping ...

Unprofitable biotech Veradermics, which still needs FDA approval for its hair loss pill, surged on its debut day.

FAR Biotech, a computational drug discovery company, has officially relocated to Wisconsin. The move marks a significant milestone for the company, which is collaborating with the University ...

A major biotech company has announced plans to lay off more than 100 positions from its Franklin, Massachusetts, facility. According to a Workers Adjustment and Retraining Notification notice, layoffs ...

Dash Bio launched two years ago, and until now its only facility was in downtown Boston.